Literature DB >> 7678315

Update on multiple sclerosis therapy.

G Mitchell1.   

Abstract

Multiple sclerosis is a demyelinating disorder of the central nervous system characterized by exacerbations and remissions of symptoms. This article deals with symptomatic therapy involving treatment of spasticity, fatigue, neurobehavioral disorders, paroxysmal disorders, pain, bladder dysfunction, and cerebellar dysfunction. This article also reviews immunosuppressive therapies including treatment of acute exacerbations or overall progression of the disorder with resultant accumulation of disability.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678315     DOI: 10.1016/s0025-7125(16)30281-4

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  4 in total

Review 1.  Outcomes assessment of drug treatment in multiple sclerosis clinical trials.

Authors:  M Malone; B Lomaestro
Journal:  Pharmacoeconomics       Date:  1996-03       Impact factor: 4.981

Review 2.  Drugs used to treat spasticity.

Authors:  M Kita; D E Goodkin
Journal:  Drugs       Date:  2000-03       Impact factor: 11.431

3.  Anesthetic management of the emergency laparotomy for a patient with multiple sclerosis -A case report-.

Authors:  Ki Hwa Lee; Jang Su Park; Sang Il Lee; Ji Yeon Kim; Kyeong Tae Kim; Won Ju Choi; Jeong Won Kim
Journal:  Korean J Anesthesiol       Date:  2010-11-25

4.  Influence of histocompatibility genes on disease susceptibility and treatment response in patients with relapsing-remitting multiple sclerosis treated with interferon β-1a.

Authors:  Shlomo Flechter; Tirza Klein; Lea Pollak
Journal:  Neurol Int       Date:  2011-06-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.